Cargando…

Generation and Effect Testing of a SARS-CoV-2 RBD-Targeted Polyclonal Therapeutic Antibody Based on a 2-D Airway Organoid Screening System

Coronavirus disease 2019 (COVID-19) is an acute respiratory infectious disease caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The US FDA has approved several therapeutics and vaccines worldwide through the emergency use authorization in response to the rapid s...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yunjiao, Qu, Jing, Wei, Lan, Liao, Shumin, Zheng, Nianzhen, Liu, Yingzi, Wang, Xingyun, Jing, Yue, Shen, Clifton Kwang-Fu, Ji, Chong, Luo, Guxun, Zhang, Yiyun, Xiang, Qi, Fu, Yang, Li, Shuo, Fan, Yunping, Fang, Shisong, Wang, Peng, Li, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559598/ https://www.ncbi.nlm.nih.gov/pubmed/34733269 http://dx.doi.org/10.3389/fimmu.2021.689065

Ejemplares similares

Evaluating Bacterial Pathogenesis Using a Model of Human Airway Organoids Infected with Pseudomonas aeruginosa Biofilms
por: Tang, Mingxing, et al.
Publicado: (2022)

Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants
por: Liu, Cong, et al.
Publicado: (2022)

Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2
por: Lin, Yifan, et al.
Publicado: (2022)

Non-clinical safety assessment and in vivo biodistribution of CoviFab, an RBD-specific F(ab′)2 fragment derived from equine polyclonal antibodies
por: Salinas, Facundo, et al.
Publicado: (2022)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Safety and effectiveness of RBD-specific polyclonal equine F(ab´)(2) fragments for the treatment of hospitalized patients with severe Covid-19 disease: A retrospective cohort study
por: Farizano Salazar, Diego H., et al.
Publicado: (2022)

Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection
por: Duan, Xiaohua, et al.
Publicado: (2021)

Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2
por: Sun, Yi-Sheng, et al.
Publicado: (2021)

Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction
por: Fu, Wenyu, et al.
Publicado: (2020)

The Cloning and Characterization of the Enolase2 Gene of Gekko japonicus and Its Polyclonal Antibody Preparation
por: Li, Jing, et al.
Publicado: (2013)

Delivery of spike-RBD by bacterial type three secretion system for SARS-CoV-2 vaccine development
por: Zhou, Yuchen, et al.
Publicado: (2023)

RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor
por: Sinha, Siddharth, et al.
Publicado: (2021)

Generalized EEG Slowing Across Phasic REM Sleep, Not Subjective RBD Severity, Predicts Neurodegeneration in Idiopathic RBD
por: Gong, Si-Yi, et al.
Publicado: (2022)

Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in mice
por: Song, Shuo, et al.
Publicado: (2022)

Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2
por: Elbadawi, Mohamed, et al.
Publicado: (2020)

Contribution of dsRBD2 to PKR Activation
por: Hesler, Stephen, et al.
Publicado: (2021)

A Vaccine of SARS-CoV-2 S Protein RBD Induces Protective Immunity
por: Qu, Qiaoqiao, et al.
Publicado: (2022)

Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2
por: Liang, Yu, et al.
Publicado: (2022)

RBD-specific polyclonal F(ab´)(2) fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial
por: Lopardo, Gustavo, et al.
Publicado: (2021)

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
por: Cao, Yunlong, et al.
Publicado: (2022)

Conjugation of R-Phycoerythrin to a Polyclonal Antibody and F (ab')2 Fragment of a Polyclonal Antibody by Two Different Methods
por: Mahmoudian, Jafar, et al.
Publicado: (2010)

Apical-Out Human Airway Organoids Modeling SARS-CoV-2 Infection
por: Chiu, Man Chun, et al.
Publicado: (2023)

Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
por: Liu, Xiaofeng, et al.
Publicado: (2023)

Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
por: Lan, Jun, et al.
Publicado: (2022)

Cross-species binding spectrum of ACE2 to SARS-CoV-2 RBD
por: Liao, Xihao, et al.
Publicado: (2022)

Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells
por: Gerez, Guillaume, et al.
Publicado: (2022)

Entropic contribution of ACE2 glycans to RBD binding
por: Mugnai, Mauro L., et al.
Publicado: (2023)

Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection
por: Fu, Yuxuan, et al.
Publicado: (2021)

Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
por: Zhou, Yunjiao, et al.
Publicado: (2021)

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
por: Junker, Daniel, et al.
Publicado: (2022)

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
por: Cao, Yunlong, et al.
Publicado: (2021)

Mycobacteria–host interactions in human bronchiolar airway organoids
por: Iakobachvili, Nino, et al.
Publicado: (2021)

Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding
por: Lin, Sheng, et al.
Publicado: (2022)

Resistant prolactinoma: Is it monoclonal or polyclonal?
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)

Mimicking acute airway tissue damage using femtosecond laser nanosurgery in airway organoids
por: Gentemann, Lara, et al.
Publicado: (2023)

Establishing Bipotential Human Lung Organoid Culture System and Differentiation to Generate Mature Alveolar and Airway Organoids
por: Chiu, Man Chun, et al.
Publicado: (2023)

Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice
por: Gao, Feng-Xia, et al.
Publicado: (2022)

Differentiated human airway organoids to assess infectivity of emerging influenza virus
por: Zhou, Jie, et al.
Publicado: (2018)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0737jamrt0881t9aii821gi5ac